# TIBURON BIO INC.: Local Neoadjuvant Immunotherapy to Reduce Recurrence in Resectable Oral Cancers

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | TIBURON BIO INC. |
| Location | SPRING, TX |
| Project | Local Neoadjuvant Immunotherapy to Reduce Recurrence in Resectable Oral Cancers |
| Project number | 1R43CA302284-01A1 |
| Mechanism | R43 |
| Institute | National Cancer Institute |
| Award | $305,488 |
| Awarded | 2026-09-01 |
| Project period | 2026-09-01 to 2027-08-31 |
| UEI | UU95AJKBS2W5 |

## Why this score
- Award of $305,488.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409869). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.